Opening of Information Collection Website for the Project for Establishing a Public-Private Joint Demonstration Platform for Dementia Sufferers
October 31, 2018
The Ministry of Economy, Trade and Industry has been advancing the Project for Establishing a Public-Private Joint Demonstration Platform for Dementia Sufferers, which is commissioned to the Japan Agency for Medical Research and Development (AMED)
As part of the project, a website for information collection was opened on the AMED website.
The number of dementia patients in Japan was approximately 4.62 million in 2012 and is estimated to increase to approximately 7 million in 2025. The shortage of nursing care-related workers may increase to approximately 0.79 million positions unfilled by 2035. Treatment using medication is indispensable, but dementia medication has yet to be well-established or standardized.
In addition to research and development of new medications and initiatives by medical and welfare organizations, it is important to involve a wide range of daily life-related industries and to utilize new businesses to facilitate the development and public implementation of new products and services that can reduce and/or prevent risks of dementia that don’t rely exclusively on medications, or that would assist patients to live independently with their remaining faculties while maintaining their dignity.
Against this backdrop, METI launched a roundtable of experts this fiscal year, as a project commissioned to the AMED, with the aim of establishing a public-private joint platform to create new products and services that are "friendly to dementia patients"--a goal set in the Strategy for Investments for the Future, 2018, approved by the Cabinet on June 15, 2018.
The website openly accepts information on the following needs and seeds concerning reduction and prevention of risks of dementia and supporting the livelihoods and societal acceptance of dementia sufferers.
METI will utilize collected information as reference materials for discussions at the expert meetings of the roundtable under the Project for Establishing a Public-Private Joint Demonstration Platform for Dementia Patients. Additionally, collected information will be open to those organizations that have collected information (companies and local governments, etc.), as well as broadly open to the general public, in order to facilitate voluntary and organic matching efforts among academia, private companies, municipalities and nursing care providers, etc., thereby aiming to accelerate the development and public implementation of new products and services that are "friendly to dementia patients."
[Needs and Seeds]
- Screening (Tests/Evaluation scales)
Products and services for detecting or verifying dementia and cognitive decline and scales for evaluation
- Solutions - Reduction and/or prevention of risks
Products and services that can reduce and/or prevent risks of dementia and cognitive decline
- Solutions support daily life of sufferers and societal acceptance
Products and services that will support daily lives of dementia patients and persons suffering from cognitive declines both at home and in public
- Experts and end-user consultants in the field
Local governments and nursing care providers, etc. that are willing to cooperate with private companies aiming to develop and implement products or services related to topics mentioned in (i) to (iii)
3. Registration Method
See the following website of the AMED.
- Website of AMED for introduction concerning information collection on dementia-related tests, scales for evaluation, solutions and experts and end-user consultants in the field (in Japanese)
4. Publication of Registered Information
Collected information is scheduled to be compiled first at the end of November and to be publicized in early December this year.
Information registered is to be publicized on a regular basis thereafter.
Division in Charge
Healthcare Industries Division, Commerce and Service Industry Policy Group